Advertisement

Topics

Maraviroc-containing Regimens Appear Safe for HIV PrEP in Women

12:01 EDT 22 Aug 2017 | Medscape

Maraviroc-containing regimens appear to be safe and well tolerated, compared with tenofovir-emtricitabine (TDF-FTC), for preventing HIV infection in women, according to results from a phase 2 trial.
Reuters Health Information

Original Article: Maraviroc-containing Regimens Appear Safe for HIV PrEP in Women

NEXT ARTICLE

More From BioPortfolio on "Maraviroc-containing Regimens Appear Safe for HIV PrEP in Women"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Reverse Transcriptase
Reverse transcriptase (RT) is an enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. It is mainly associated with retroviruses. RT inhibitors are widely used as antiretroviral drugs. RT activitie...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...